{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:29:08Z","timestamp":1792013348821,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","id.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.idc.2017.07.014","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T16:31:35Z","timestamp":1509035495000},"page":"827-838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Hepatitis C Virus Infection in the Older Patient"],"prefix":"10.1016","volume":"31","author":[{"given":"Michael","family":"Reid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis C.","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.idc.2017.07.014_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2017.07.014_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-156-4-201202210-00378","article-title":"The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings","volume":"156","author":"Rein","year":"2012","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.idc.2017.07.014_bib3","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"RR-4","key":"10.1016\/j.idc.2017.07.014_bib4","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965","volume":"61","author":"Smith","year":"2012","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.idc.2017.07.014_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2105\/AJPH.2013.301549","article-title":"Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008","volume":"104","author":"Smith","year":"2014","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.idc.2017.07.014_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11908-016-0518-9","article-title":"Burden of hepatitis C virus infection among older adults in long-term care settings: a systematic review of the literature and meta-analysis","volume":"18","author":"Alvarez","year":"2016","journal-title":"Curr Infect Dis Rep"},{"issue":"3","key":"10.1016\/j.idc.2017.07.014_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/hep.25688","article-title":"Case-control study of hepatitis B and hepatitis C in older adults: do healthcare exposures contribute to burden of new infections?","volume":"57","author":"Perz","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.idc.2017.07.014_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-9506","article-title":"Epidemiology of hepatitis C: geographic differences and temporal trends","volume":"20","author":"Wasley","year":"2000","journal-title":"Semin Liver Dis"},{"issue":"5","key":"10.1016\/j.idc.2017.07.014_bib9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","article-title":"Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010","volume":"160","author":"Denniston","year":"2014","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2017.07.014_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2000-9505","article-title":"Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome","volume":"20","author":"Alter","year":"2000","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.idc.2017.07.014_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/jlts.2003.50073","article-title":"Projecting future complications of chronic hepatitis C in the United States","volume":"9","author":"Davis","year":"2003","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.idc.2017.07.014_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1089-3261(05)70328-7","article-title":"Hepatitis C infection in transplantation","volume":"1","author":"Pessoa","year":"1997","journal-title":"Clin Liver Dis"},{"issue":"9","key":"10.1016\/j.idc.2017.07.014_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/jvh.12533","article-title":"Epidemiology and outcomes of hepatitis C infection in elderly US Veterans","volume":"23","author":"El-Serag","year":"2016","journal-title":"J\u00a0Viral Hepat"},{"issue":"3","key":"10.1016\/j.idc.2017.07.014_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1478-3231.2006.01430.x","article-title":"Progression to cirrhosis in hepatitis C patients: an age-dependent process","volume":"27","author":"Pradat","year":"2007","journal-title":"Liver Int"},{"issue":"22","key":"10.1016\/j.idc.2017.07.014_bib15","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM199506013322202","article-title":"Clinical outcomes after transfusion-associated hepatitis C","volume":"332","author":"Tong","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.idc.2017.07.014_bib16","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1182\/blood-2001-12-0192","article-title":"Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C","volume":"99","author":"Minola","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.idc.2017.07.014_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1600-6143.2005.00741.x","article-title":"Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis","volume":"5","author":"Lake","year":"2005","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.idc.2017.07.014_bib18","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c","volume":"34","author":"Poynard","year":"2001","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.idc.2017.07.014_bib19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1440-1746.1995.tb01088.x","article-title":"Interferon therapy for patients more than 60 years of age with chronic hepatitis C","volume":"10","author":"Horiike","year":"1995","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.idc.2017.07.014_bib20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/eci.12429","article-title":"Increased frequency of late-senescent T\u00a0cells lacking CD127 in chronic hepatitis C disease","volume":"45","author":"Barathan","year":"2015","journal-title":"Eur J Clin Invest"},{"issue":"9","key":"10.1016\/j.idc.2017.07.014_bib21","first-page":"1680","article-title":"T\u00a0cell replicative senescence in human aging","volume":"19","author":"Chou","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"7","key":"10.1016\/j.idc.2017.07.014_bib22","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/cncr.30559","article-title":"Hepatitis C virus infection and the risk of cancer among elderly US adults: a registry-based case-control study","volume":"123","author":"Mahale","year":"2017","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.idc.2017.07.014_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0168-8278(92)90073-X","article-title":"Infection of peripheral mononuclear blood cells by hepatitis C virus","volume":"15","author":"Zignego","year":"1992","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.idc.2017.07.014_bib24","doi-asserted-by":"crossref","first-page":"980942","DOI":"10.1155\/2012\/980942","article-title":"HCV and lymphoproliferation","volume":"2012","author":"Zignego","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"5","key":"10.1016\/j.idc.2017.07.014_bib25","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.27664","article-title":"Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans","volume":"61","author":"Molnar","year":"2015","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.idc.2017.07.014_bib26","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jvh.12413","article-title":"A\u00a0meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection","volume":"22","author":"Park","year":"2015","journal-title":"J\u00a0Viral Hepat"},{"issue":"1","key":"10.1016\/j.idc.2017.07.014_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.03710708","article-title":"Hepatitis C infection and chronic renal diseases","volume":"4","author":"Perico","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.idc.2017.07.014_bib28","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ki.2013.455","article-title":"A\u00a0nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease","volume":"85","author":"Chen","year":"2014","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.idc.2017.07.014_bib29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/QAI.0b013e3181b980d4","article-title":"Hepatitis C and the risk of kidney disease and mortality in veterans with HIV","volume":"53","author":"Fischer","year":"2010","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.idc.2017.07.014_bib30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.ajkd.2014.01.428","article-title":"Nephropathy in illicit drug abusers: a postmortem analysis","volume":"63","author":"Buettner","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.idc.2017.07.014_bib31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/cid\/ciu919","article-title":"End-stage renal disease among HIV-infected adults in North America","volume":"60","author":"Abraham","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2017.07.014_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2893.2011.01554.x","article-title":"Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity","volume":"19","author":"Stepanova","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"issue":"Suppl 2","key":"10.1016\/j.idc.2017.07.014_bib33","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12072-013-9460-1","article-title":"Insulin resistance, steatosis and hepatitis C virus","volume":"7","author":"Mangia","year":"2013","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.idc.2017.07.014_bib34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/apt.12234","article-title":"Associations of chronic hepatitis C with metabolic and cardiac outcomes","volume":"37","author":"Younossi","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.idc.2017.07.014_bib35","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1053\/jhep.2001.0103306le01","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"33","author":"Mehta","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.idc.2017.07.014_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/jhep.2003.50291","article-title":"Hepatitis C virus infection and incident type 2 diabetes","volume":"38","author":"Mehta","year":"2003","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.idc.2017.07.014_bib37","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/oxfordjournals.epirev.a000808","article-title":"Association between hepatitis C virus infection and diabetes mellitus","volume":"23","author":"Mehta","year":"2001","journal-title":"Epidemiol Rev"},{"issue":"11","key":"10.1016\/j.idc.2017.07.014_bib38","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3748\/wjg.v20.i11.2888","article-title":"Interaction between hepatitis C virus and metabolic factors","volume":"20","author":"Kawaguchi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.idc.2017.07.014_bib39","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.hep.2003.09.012","article-title":"Impaired IRS-1\/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes","volume":"38","author":"Aytug","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.idc.2017.07.014_bib40","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0002-9440(10)63408-6","article-title":"Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3","volume":"165","author":"Kawaguchi","year":"2004","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.idc.2017.07.014_bib41","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1572-0241.2006.01038.x","article-title":"Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2","volume":"102","author":"Kawaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.idc.2017.07.014_bib42","first-page":"89","article-title":"Selective photosensitization of human leukemic cells by a pyrene-containing fatty acid","volume":"18","author":"Fibach","year":"1990","journal-title":"Exp Hematol"},{"issue":"2","key":"10.1016\/j.idc.2017.07.014_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijcard.2011.07.016","article-title":"Effects of hepatitis C virus on cardiovascular risk in infected patients: a comparative study","volume":"164","author":"Oliveira","year":"2013","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.idc.2017.07.014_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcv.2009.10.005","article-title":"Hepatitis C virus RNA localization in human carotid plaques","volume":"47","author":"Boddi","year":"2010","journal-title":"J\u00a0Clin Virol"},{"issue":"2","key":"10.1016\/j.idc.2017.07.014_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0009-8981(97)06532-7","article-title":"Blood lipids of patients with chronic hepatitis: differences related to viral etiology","volume":"261","author":"Fabris","year":"1997","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1016\/j.idc.2017.07.014_bib46","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J\u00a0Lipid Res"},{"issue":"1","key":"10.1016\/j.idc.2017.07.014_bib47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2893.2005.00655.x","article-title":"Serum lipid pattern in chronic hepatitis C: histological and virological correlations","volume":"13","author":"Siagris","year":"2006","journal-title":"J\u00a0Viral Hepat"},{"issue":"12","key":"10.1016\/j.idc.2017.07.014_bib48","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1023\/A:1021040702370","article-title":"Assessment of fatigue in patients with chronic hepatitis C using the Fatigue Impact Scale","volume":"47","author":"Hassoun","year":"2002","journal-title":"Dig Dis Sci"},{"issue":"11","key":"10.1016\/j.idc.2017.07.014_bib49","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gut.2006.100081","article-title":"Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition?","volume":"55","author":"Forton","year":"2006","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.idc.2017.07.014_bib50","first-page":"484","article-title":"Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests","volume":"32","author":"Casato","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.idc.2017.07.014_bib51","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/gut.2005.080267","article-title":"Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment","volume":"55","author":"Weissenborn","year":"2006","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.idc.2017.07.014_bib52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10620-007-9896-z","article-title":"Cognitive dysfunction in chronic hepatitis C: a review","volume":"53","author":"Perry","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.idc.2017.07.014_bib53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0168-8278(02)00172-1","article-title":"Subclinical impairment of brain function in chronic hepatitis C infection","volume":"37","author":"Kramer","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.idc.2017.07.014_bib54","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jhep.2005.04.006","article-title":"Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial","volume":"43","author":"Fontana","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"19","key":"10.1016\/j.idc.2017.07.014_bib55","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1128\/JVI.76.19.10064-10068.2002","article-title":"Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid","volume":"76","author":"Laskus","year":"2002","journal-title":"J\u00a0Virol"},{"issue":"4","key":"10.1016\/j.idc.2017.07.014_bib56","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s13365-011-0039-0","article-title":"Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling","volume":"17","author":"Paulino","year":"2011","journal-title":"J\u00a0Neurovirol"},{"issue":"3","key":"10.1016\/j.idc.2017.07.014_bib57","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/519285","article-title":"Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV","volume":"196","author":"Letendre","year":"2007","journal-title":"J\u00a0Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2017.07.014_bib58","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/hepr.12419","article-title":"Efficacy and safety of interferon treatment in elderly patients with chronic hepatitis C in Japan: a retrospective study using the Japanese Interferon Database","volume":"45","author":"Sato","year":"2015","journal-title":"Hepatol Res"},{"issue":"3","key":"10.1016\/j.idc.2017.07.014_bib59","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10620-007-9926-x","article-title":"Treatment eligibility and outcomes in elderly patients with chronic hepatitis C: results from the VA HCV-001 Study","volume":"53","author":"Tsui","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.idc.2017.07.014_bib60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.gastro.2016.05.049","article-title":"Effectiveness of sofosbuvir, ledipasvir\/sofosbuvir, or paritaprevir\/ritonavir\/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the Veterans Affairs National Health Care System","volume":"151","author":"Ioannou","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.idc.2017.07.014_bib61","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/hep.28425","article-title":"Safety and efficacy of ledipasvir\/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older","volume":"63","author":"Saab","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.idc.2017.07.014_bib62","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/MEG.0000000000000858","article-title":"Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients","volume":"29","author":"Su","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.idc.2017.07.014_bib63","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.28535","article-title":"Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection","volume":"64","author":"El-Serag","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.idc.2017.07.014_bib64","series-title":"DAAs improve VACS but do not influence cognitive impairment in HIV\/HCV coinfected","author":"Mastrorosa","year":"2017"},{"issue":"8","key":"10.1016\/j.idc.2017.07.014_bib65","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1468-1293.2007.00505.x","article-title":"Improved cognitive function as a consequence of hepatitis C virus treatment","volume":"8","author":"Thein","year":"2007","journal-title":"HIV Med"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552017300685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552017300685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T13:51:02Z","timestamp":1535291462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552017300685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0891552017300685"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2017.07.014","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C Virus Infection in the Older Patient","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2017.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}